Corner office podcast: Pfizer patent chief on vaccine IP and the waiver

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Corner office podcast: Pfizer patent chief on vaccine IP and the waiver

4054a3b0-c086-469f-b541-4458ebc7bce4bryan-zielinski-chief-patent-counsel-at-pfizer-web-version-4x.jpg

In Managing IP’s first corner office podcast, Bryan Zielinski talks about his company’s IP challenges and opportunities, AI, and more

In an exclusive Managing IP podcast, Pfizer chief patent counsel Bryan Zielinski talks about his company’s patent operations and delves into the proposed COVID intellectual property waiver being discussed at the World Trade Organization.

He also discusses the important technologies that his company is working on and how his teams ensure they get sufficient patent protection, and even talks about the role artificial intelligence might play in future therapeutic discovery.

This is the first in a new podcast series brought to you by Managing IP. Click below to listen. 

 


 

more from across site and SHARED ros bottom lb

More from across our site

In-house counsel explain why firms should provide risk management advice that helps them achieve their goals
Attorneys at four firms explain the AI trends they expect in the future, including a potential shift in who plaintiffs sue for copyright infringement
The dispute at the Intellectual Property Enterprise Court pits Dryrobe against D-Robe and will include a ‘genericide’ element
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
The court will hand down its ruling in Iconix v Dream Pairs on Tuesday, June 24, in a case that concerns post-sale confusion
Developments included a stay in a row concerning the UPC’s jurisdiction and a timeline for the rollout of the long-awaited new CMS
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Companies must conduct thorough IP due diligence – even if it may not be mandatory
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio
A team of partners that joined Boies Schiller Flexner say they would like to double the firm’s patent litigation capabilities
Gift this article